Table 1. Survival and cohort retention of HIV/AIDS patients who started HAART and diabetes patients who started treatment in chronic disease clinics, Takeo and Siem Reap.
| Months on treatment | 0–3 | 3–6 | 6–12 | 12–18 | 12–24 | 24+ | |
|---|---|---|---|---|---|---|---|
| HIV patients | |||||||
| N | 2 497a | 2 317 | 1 906 | 1 288 | 691 | 300 | 289 |
| Deaths (cumulative) | 110 | 37 (147) | 34 (181) | 16 (197) | 4 (201) | 0 (201) | |
| Lost to follow-up (cumulative) | 36 | 19 (55) | 15 (70) | 7 (77) | 1 (78) | 2 (80) | |
| Transfer out to other service (cumulative) | 25 | 48 (73) | 80 (153) | 58 (211) | 13 (224) | 3 (227) | |
| Median CD4 count (cells/mm³) | 53 | 154 | 180 | 218 | 269 | 309 | 344 |
| % remaining in careb | 94.1 | 91.7 | 89.3 | 88 | 87.7 | 87.6 | |
| Diabetes patients | |||||||
| N | 2 638a | 2 484 | 1 795 | 1 321 | 801 | 457 | 25 |
| Deaths (cumulative) | 0 | 0 | 2 | 0 | 0 | 1 (3) | |
| Lost to follow-up (cumulative) | 487 | 91 (578) | 116 (694) | 52 (746) | 15 (761) | 9 (770) | |
| Transfer out to other service (cumulative) | 1 | 0 | 1 | 1 | 0 | 0 | |
| % remaining in careb | 81.5 | 78.1 | 73.6 | 71.6 | 71 | 70.7 |
a All patients who started HAART or diabetes treatment in the chronic disease clinics of Siem Reap or Takeo. b Kaplan–Meier survival estimate.